Back

Loss of pulsatility during impella support: incidence, predictors, and impact on short- and long-term outcomes from the IMMERGE registry

31 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Myocarditis to cardiogenic shock: mechanisms and outcomes Cardiogenic Shock ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Federico Giacobbe

Hospital Citta Della Salute e della Scienza di Torino, Turin (Italy)

6 More presentations in this session

Presentation thumbnail
Prediction of in-hospital mortality in cardiogenic shock using blood gas analysis data and a neural network model
Doctor A. Zapolska-Tomasiewicz (Wroclaw, PL)
Abstract Slides Video
Presentation thumbnail
Concordance between E/e′ratio and NT-proBNP levels for predicting late-onset heart failure events in patients with acute coronary syndrome(CONCORD-ACS Study)
Doctor K. Kimavaha (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Clinical association between hypoxic liver injury and hypoxic hepatitis in cardiogenic shock patients regarding in-hospital and 12 months mortality: from the RESCUE II trial
Doctor S. Choi (Incheon, KR)
Abstract Slides Video
Presentation thumbnail
Left ventricular unloading with impella versus IABP in cardiogenic shock requiring VA-ECMO
Doctor R. Ito (Nagoya, JP)
Abstract Slides Video
Presentation thumbnail
Clinical predictors of in-hospital mortality in adult patients with refractory cardiogenic shock or cardiac arrest supported with veno-arterial extracorporeal membrane oxygenation
Doctor A. Carugno (Buenos Aires, AR)
Abstract Slides Video

Access the full session

Session thumbnail
Myocarditis to cardiogenic shock: mechanisms and outcomes

The Event

Event poster

ESC Congress 2026

31 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Long term outcomes in patients undergoing Impella protected high-risk percutaneous coronary intervention: insights from the international IMMERGE registry
30 August 2026
thumbnail
Congress Presentation
Temporal trend of hemodynamic functional indices in isolated PVAD and combined therapy with VA-ECMO
31 August 2025
thumbnail
Congress Presentation
Etiology-specific outcomes in refractory cardiogenic shock treated with Impella 2.5/CP: a 8-year real-world cohort
31 August 2026
thumbnail
Congress Presentation
Outcomes of Impella 5.5/CP use in acute on chronic heart failure: a single center case series
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources